NASDAQ:IKNX - IKONICS Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$10.5001 0.00 (0.00 %)
(As of 06/25/2018 10:28 AM ET)
Previous Close$10.5001
Today's Range$10.51 - $10.51
52-Week Range$7.25 - $13.03
Volume5 shs
Average Volume5,301 shs
Market Capitalization$20.83 million
P/E Ratio1,050.01
Dividend YieldN/A
Beta0.03
IKONICS Corporation develops, manufactures, and sells photosensitive liquids and films for screen printing, awards and recognition, and dye sublimation markets primarily in the United States and Canada. It operates through five segments: Domestic, Export, IKONICS Imaging, Digital Texturing Technology, and Advanced Material Solutions. The company sells screen printing films, emulsions, and inkjet receptive films to distributors; and photo resistant films, art supplies, glass, metal medium, and related abrasive etching equipment to end user customers. It also provides sound deadening technology to the aerospace industry; products and services for etched composites, ceramics, glass, and silicon wafers; and products related to proprietary inkjet technology used for mold texturing and prototyping. The company markets and sells its products directly, as well as through domestic and international distributors, magazine advertising, trade shows, and Internet. IKONICS Corporation also exports its products to North America, Europe, Latin America, and Asia. The company was formerly known as The Chromaline Corporation and changed its name to IKONICS Corporation in December 2002. IKONICS Corporation was founded in 1952 and is headquartered in Duluth, Minnesota.

Receive IKNX News and Ratings via Email

Sign-up to receive the latest news and ratings for IKNX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Photographic equipment & supplies
Sub-IndustryN/A
SectorIndustrial Products
SymbolNASDAQ:IKNX
CUSIPN/A
Phone218-628-2217

Debt

Debt-to-Equity Ratio0.23
Current Ratio7.84
Quick Ratio5.66

Price-To-Earnings

Trailing P/E Ratio1,050.01
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$17.24 million
Price / Sales1.21
Cash Flow$0.3233 per share
Price / Cash32.48
Book Value$6.50 per share
Price / Book1.62

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-220,000.00
Net Margins0.12%
Return on Equity0.17%
Return on Assets0.13%

Miscellaneous

Employees83
Outstanding Shares1,980,000

The Truth About Cryptocurrencies

IKONICS (NASDAQ:IKNX) Frequently Asked Questions

What is IKONICS's stock symbol?

IKONICS trades on the NASDAQ under the ticker symbol "IKNX."

How will IKONICS's stock buyback program work?

IKONICS declared that its board has approved a stock buyback program on Friday, August 4th 2017, which allows the company to repurchase 100,000 shares, according to EventVestor. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company's management believes its shares are undervalued.

How were IKONICS's earnings last quarter?

IKONICS Co. (NASDAQ:IKNX) issued its earnings results on Thursday, April, 26th. The specialty chemicals company reported ($0.07) earnings per share (EPS) for the quarter. The specialty chemicals company earned $4.07 million during the quarter. IKONICS had a net margin of 0.12% and a return on equity of 0.17%. View IKONICS's Earnings History.

When is IKONICS's next earnings date?

IKONICS is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for IKONICS.

Who are some of IKONICS's key competitors?

Who are IKONICS's key executives?

IKONICS's management team includes the folowing people:
  • Mr. William C. Ulland, Chairman, CEO and Pres (Age 77)
  • Mr. Jon R. Gerlach, CFO, VP of Fin. and Sec. (Age 51)
  • Mr. Claude P. Piguet, Exec. VP (Age 60)
  • Mr. Kenneth D. Hegman, Chief Operating Officer (Age 47)

Has IKONICS been receiving favorable news coverage?

News coverage about IKNX stock has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. IKONICS earned a media sentiment score of 0.13 on Accern's scale. They also gave news articles about the specialty chemicals company an impact score of 44.39 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of IKONICS?

Shares of IKNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IKONICS's stock price today?

One share of IKNX stock can currently be purchased for approximately $10.5001.

How big of a company is IKONICS?

IKONICS has a market capitalization of $20.83 million and generates $17.24 million in revenue each year. IKONICS employs 83 workers across the globe.

How can I contact IKONICS?

IKONICS's mailing address is 4832 GRAND AVENUE, DULUTH MN, 55807. The specialty chemicals company can be reached via phone at 218-628-2217 or via email at [email protected]


MarketBeat Community Rating for IKONICS (IKNX)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  95
MarketBeat's community ratings are surveys of what our community members think about IKONICS and other stocks. Vote "Outperform" if you believe IKNX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IKNX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.